{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:09Z","timestamp":1791925389320,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Municipal Health Commission Foundation","award":["202040386"],"award-info":[{"award-number":["202040386"]}]},{"name":"the medical key faculty foundation of shanghai","award":["ZK2019B15"],"award-info":[{"award-number":["ZK2019B15"]}]},{"DOI":"10.13039\/501100013098","name":"scientific and innovative action plan of shanghai","doi-asserted-by":"publisher","award":["21S31901800"],"award-info":[{"award-number":["21S31901800"]}],"id":[{"id":"10.13039\/501100013098","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Shanghai Plan for Women and Children's Health Service Capacity Construction","award":["The Shanghai Plan for Women and Children's Health Service Capacity Construction"],"award-info":[{"award-number":["The Shanghai Plan for Women and Children's Health Service Capacity Construction"]}]},{"name":"key medical specialty funded by shanghai fifth people's hospital, fudan university","award":["2018WYZD004"],"award-info":[{"award-number":["2018WYZD004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although insulin therapy achieves effective glycemic control, it may aggravate hyperinsulinemia. Nonetheless the benefits of insulin as first-line treatment for women with GDM are controversial. This work aimed to investigate the effect of insulin on maternal GDM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective cohort study recruited 708 women with GDM of whom 616 underwent lifestyle intervention and 92 were prescribed insulin therapy. Differences in variables between the two groups were analyzed by univariate analysis and multivariate analysis. Propensity score matching was used to control for age, pre-pregnancy BMI, time and BP at GDM diagnosis, and family history of diabetes and hypertension. Paired sample test was applied to evaluate the changes in BP after intervention in the two groups of women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was no significant difference in mode of delivery, newborn weight or incidence of macrosomia between women prescribed insulin and those who adopted lifestyle modifications. Insulin therapy was associated with a slight increase in maternal weight compared with the lifestyle intervention group and was attributed to short-term treatment (about 12 weeks). In addition, insulin therapy remarkably increased maternal blood pressure, an effect that persisted after matching age, pre-pregnancy BMI, time and BP at GDM diagnosis, and family history of diabetes and hypertension. Between commencing insulin therapy and delivery, systolic blood pressure significantly increased by 6mmHg (<jats:italic>P<\/jats:italic>\u2009=\u20090.015) and diastolic blood pressure by 9 mmHg (<jats:italic>P<\/jats:italic> &lt; 0.001). Increase in BP was significantly higher in the insulin group compared with the lifestyle intervention group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Logistic regression analysis with enter selection confirmed that insulin therapy was closely correlated with development of gestational hypertension (GH).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This work suggested that short-term insulin therapy for GDM was associated with a slight increase in maternal weight but a significant risk of increasing maternal blood pressure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-04066-z","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T10:20:05Z","timestamp":1632738005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effects of insulin therapy on maternal blood pressure and weight in women with gestational diabetes mellitus"],"prefix":"10.1186","volume":"21","author":[{"given":"Tiange","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanhua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufei","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"issue":"1","key":"4066_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2337\/dc19-S002","volume":"42","author":"D American","year":"2019","unstructured":"American D, Care AJD. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42:13\u201328. https:\/\/doi.org\/10.2337\/dc19-S002.","journal-title":"Diabetes Care"},{"issue":"4","key":"4066_CR2","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/dc11-1790","volume":"35","author":"PM Catalano","year":"2012","unstructured":"Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JJ. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35(4):780\u20136. https:\/\/doi.org\/10.2337\/dc11-1790.","journal-title":"Diabetes Care"},{"issue":"5","key":"4066_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2337\/dc16-2397","volume":"40","author":"WH Tam","year":"2017","unstructured":"Tam WH, Ma RCW, Ozaki R, Li AM, Chan MHM, Yuen LY, Lao TTH, Yang X, Ho CS, Tutino GE, Chan JCN. In Utero Exposure to Maternal Hyperglycemia Increases Childhood Cardiometabolic Risk in Offspring. Diabetes Care. 2017;40(5):679\u201386. https:\/\/doi.org\/10.2337\/dc16-2397.","journal-title":"Diabetes Care"},{"key":"4066_CR4","doi-asserted-by":"publisher","unstructured":"Ovesen PG, Jensen DM, Damm P, Rasmussen S, Kesmodel US. Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. a nation-wide study. J Matern Fetal Neonatal Med. 2015;28(14):1720\u201324. https:\/\/doi.org\/10.3109\/14767058.2014.966677.","DOI":"10.3109\/14767058.2014.966677"},{"key":"4066_CR5","doi-asserted-by":"publisher","unstructured":"Yogev Y, Xenakis EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol. 2004;191(5):1655\u201360. https:\/\/doi.org\/10.1016\/j.ajog.2004.03.074.","DOI":"10.1016\/j.ajog.2004.03.074"},{"key":"4066_CR6","doi-asserted-by":"publisher","unstructured":"Ehrenberg HM, Durnwald CP, Catalano P, Mercer BM. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol. 2004;191(3):969\u201374. https:\/\/doi.org\/10.1016\/j.ajog.2004.06.057.","DOI":"10.1016\/j.ajog.2004.06.057"},{"issue":"1","key":"4066_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1479-828X.2011.01292.x","volume":"51","author":"WT Teh","year":"2011","unstructured":"Teh WT, Teede HJ, Paul E, Harrison CL, Wallace EM, Allan C. Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aust N Z J Obstet Gynaecol. 2011;51(1):26\u201330. https:\/\/doi.org\/10.1111\/j.1479-828X.2011.01292.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"4066_CR8","doi-asserted-by":"publisher","first-page":"h102","DOI":"10.1136\/bmj.h102","volume":"350","author":"M Balsells","year":"2015","unstructured":"Balsells M, Garcia-Patterson A, Sola I, Roque M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015;350:h102. https:\/\/doi.org\/10.1136\/bmj.h102.","journal-title":"BMJ"},{"issue":"1","key":"4066_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1210\/jc.2012-2667","volume":"98","author":"N Jansson","year":"2013","unstructured":"Jansson N, Rosario FJ, Gaccioli F, Lager S, Jones HN, Roos S, Jansson T, Powell TL. Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J Clin Endocrinol Metab. 2013;98(1):105\u201313. doi:https:\/\/doi.org\/10.1210\/jc.2012-2667.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"4066_CR10","doi-asserted-by":"publisher","first-page":"e1002848","DOI":"10.1371\/journal.pmed.1002848","volume":"16","author":"JL Tarry-Adkins","year":"2019","unstructured":"Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis. PLoS Med. 2019;16(8):e1002848. https:\/\/doi.org\/10.1371\/journal.pmed.1002848.","journal-title":"PLoS Med"},{"key":"4066_CR11","doi-asserted-by":"publisher","unstructured":"Seravalle G, Grassi GJHBP, Prevention C. Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome. High Blood Press Cardiovasc Prev. 2016;23(3):1\u20135. https:\/\/doi.org\/10.1007\/s40292-016-0137-4.","DOI":"10.1007\/s40292-016-0137-4"},{"key":"4066_CR12","unstructured":"Medicine IOJNAP. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington; 2009. http:\/\/dx.doi.org\/."},{"key":"4066_CR13","doi-asserted-by":"publisher","unstructured":"Obstetrics NJAJo G. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. 2000;183(1):s1\u2013s22. https:\/\/doi.org\/10.1067\/mob.2000.107928.","DOI":"10.1067\/mob.2000.107928"},{"issue":"1","key":"4066_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4103\/2230-8210.146874","volume":"19","author":"M Gutch","year":"2015","unstructured":"Gutch M, Kumar S, Razi S, Gupta K, Gupta A. Assessment of insulin sensitivity\/resistance. Indian J Endocrinol Metabol. 2015;19(1):160. https:\/\/doi.org\/10.4103\/2230-8210.146874.","journal-title":"Indian J Endocrinol Metabol"},{"key":"4066_CR15","doi-asserted-by":"publisher","unstructured":"Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA, Zoupas C. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30 Suppl 2:S251\u2013260. https:\/\/doi.org\/10.2337\/dc07-s225.","DOI":"10.2337\/dc07-s225"},{"issue":"6","key":"4066_CR16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jog.12950","volume":"42","author":"S Ashoush","year":"2016","unstructured":"Ashoush S, El-Said M, Fathi H, Abdelnaby M. Identification of metformin poor responders, requiring supplemental insulin, during randomization of metformin versus insulin for the control of gestational diabetes mellitus. J Obstet Gynaecol Res. 2016;42(6):640\u20137. https:\/\/doi.org\/10.1111\/jog.12950.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"4066_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.diabres.2014.10.001","volume":"107","author":"J Ainuddin","year":"2015","unstructured":"Ainuddin J, Karim N, Hasan AA, Naqvi SA. Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country: a randomized control trial. Diabetes Res Clin Pract. 2015;107(2):290\u20139. https:\/\/doi.org\/10.1016\/j.diabres.2014.10.001.","journal-title":"Diabetes Res Clin Pract"},{"key":"4066_CR18","doi-asserted-by":"publisher","unstructured":"Song R, Chen L, Chen Y, Si X, Liu Y, Liu Y, Irwin DM, Feng W. Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis. PLoS One. 2017;12(8):e0182488. https:\/\/doi.org\/10.1371\/journal.pone.0182488.","DOI":"10.1371\/journal.pone.0182488"},{"key":"4066_CR19","doi-asserted-by":"publisher","unstructured":"Saleh HS, Abdelsalam WA, Mowafy HE, Abd ElHameid AA. Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin? Int J Reprod Med. 2016;2016:3480629. https:\/\/doi.org\/10.1155\/2016\/3480629.","DOI":"10.1155\/2016\/3480629"},{"key":"4066_CR20","doi-asserted-by":"publisher","unstructured":"Tertti K, Ekblad U, Koskinen P, Vahlberg T, R\u00f6nnemaa TJD, Obesity M. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab. 2013;15(3):246\u201351. https:\/\/doi.org\/10.1111\/dom.12017.","DOI":"10.1111\/dom.12017"},{"key":"4066_CR21","doi-asserted-by":"publisher","unstructured":"Guo L, Ma J, Tang J, Hu D, Zhao XJJoDR. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis. J Diabetes Res. 2019(2):1\u201329. https:\/\/doi.org\/10.1155\/2019\/9804708.","DOI":"10.1155\/2019\/9804708"},{"key":"4066_CR22","doi-asserted-by":"publisher","unstructured":"Persson B, Stangenberg M, Hansson U, Nordlander E. Gestational Diabetes Mellitus (GDM): Comparative Evaluation of Two Treatment Regimens, Diet Versus Insulin and Diet. Diabetes. 1985;34(Supplement_2):101\u2013105. https:\/\/doi.org\/10.2337\/diab.34.2.S101.","DOI":"10.2337\/diab.34.2.S101"},{"key":"4066_CR23","doi-asserted-by":"publisher","unstructured":"Coustan DR, Lewis SB. Insulin Therapy for Gestational Diabetes. Obstet Gynecol. 1978;51(3):306\u2013310. https:\/\/doi.org\/10.1097\/00006250-197803000-00010.","DOI":"10.1097\/00006250-197803000-00010"},{"key":"4066_CR24","doi-asserted-by":"publisher","unstructured":"Liu HY, Cao SY, Hong T, Han J, Liu Z, Cao WJJoBC. Insulin Is a Stronger Inducer of Insulin Resistance than Hyperglycemia in Mice with Type 1 Diabetes Mellitus (T1DM). J Biol Chem. 2009;284(40):27090. https:\/\/doi.org\/10.1074\/jbc.M109.016675.","DOI":"10.1074\/jbc.M109.016675"},{"key":"4066_CR25","doi-asserted-by":"publisher","unstructured":"Erpeldinger S, Rehman MB, Berkhout C, Pigache C, Zerbib Y, Regnault F, Gu\u00e9rin E, Supper I, Cornu C, Kassa\u00ef BJBED. Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials. BMC Endocr Disord. 2016;16(1):39. https:\/\/doi.org\/10.1186\/s12902-016-0120-z.","DOI":"10.1186\/s12902-016-0120-z"},{"key":"4066_CR26","doi-asserted-by":"publisher","unstructured":"Niromanesh S, Alavi A, Sharbaf FR, Amjadi N, Akbari SJDR, Practice C. Metformin compared with insulin in the management of gestational diabetes mellitus: A randomized clinical trial. Diabetes Res Clin Pract. 2012;98(3):422\u20139. https:\/\/doi.org\/10.1016\/j.diabres.2012.09.031.","DOI":"10.1016\/j.diabres.2012.09.031"},{"key":"4066_CR27","doi-asserted-by":"publisher","unstructured":"Wang F, Han L, Hu D. Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis. Clin Chim Acta. 2017;464:57\u201363. https:\/\/doi.org\/10.1016\/j.cca.2016.11.009.","DOI":"10.1016\/j.cca.2016.11.009"},{"issue":"3","key":"4066_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/bf00252649","volume":"21","author":"RA DeFronzo","year":"1981","unstructured":"DeFronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981;21(3):165\u201371. https:\/\/doi.org\/10.1007\/bf00252649.","journal-title":"Diabetologia"},{"key":"4066_CR29","doi-asserted-by":"publisher","unstructured":"Fonseca VA. Insulin resistance, diabetes, hypertension, and renin-angiotensin system inhibition: reducing risk for cardiovascular disease. J Clin Hypertens (Greenwich Conn). 2006;8(10):713\u201320; quiz 721\u2013712. https:\/\/doi.org\/10.1111\/j.1524-6175.2006.05583.x.","DOI":"10.1111\/j.1524-6175.2006.05583.x"},{"issue":"6","key":"4066_CR30","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/jci115260","volume":"87","author":"EA Anderson","year":"1991","unstructured":"Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Investig. 1991;87(6):2246\u201352. https:\/\/doi.org\/10.1172\/jci115260.","journal-title":"J Clin Investig"},{"issue":"8","key":"4066_CR31","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1113\/jphysiol.2011.221036","volume":"590","author":"MM Smith","year":"2012","unstructured":"Smith MM, Minson CT. Obesity and adipokines: effects on sympathetic overactivity. J Physiol. 2012;590(8):1787\u2013801. https:\/\/doi.org\/10.1113\/jphysiol.2011.221036.","journal-title":"J Physiol"},{"key":"4066_CR32","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/ajh\/hpt137","volume":"12","author":"AC Palei","year":"2013","unstructured":"Palei AC, Spradley FT, Granger JPJAJoH. Euglycemic hyperinsulinemia increases blood pressure in pregnant rats independent of placental antiangiogenic and inflammatory factors. Am J Hypertens. 2013;12:1445\u201351. https:\/\/doi.org\/10.1093\/ajh\/hpt137.","journal-title":"Am J Hypertens."},{"key":"4066_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10641963.2020.1756316","volume":"5","author":"H Wang","year":"2020","unstructured":"Wang H, Tian Y, Chen Y, Shen X, Li GJC, Hypertension E. Hyperinsulinemia rather than insulin resistance itself induces blood pressure elevation in high fat diet-fed rats. Clin Exp Hypertens. 2020;5:1\u20138. https:\/\/doi.org\/10.1080\/10641963.2020.1756316.","journal-title":"Clin Exp Hypertens."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04066-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T10:25:49Z","timestamp":1632738349000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04066-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4066"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04066-z","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"assertion":[{"value":"28 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Shanghai Fifth People\u2019s Hospital approved this study (Number: 2020 Ethics Approval. No. 154). This work is a retrospective study. Only clinical data of patients were analyzed so informed consent was not required. The study was conducted in accordance with the rules of ethics committee of Shanghai Fifth People\u2019s Hospital. Access and use of the medical records were permitted by the medical department and information center of Shanghai Fifth People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as above.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"657"}}